<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Klein K</submitter><funding>Luxembourg National Research Fund</funding><funding>Foundation Cancer Luxembourg</funding><pagination>979</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10935394</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>29(5)</volume><pubmed_abstract>Understanding and classifying inherent tumor heterogeneity is a multimodal approach, which can be undertaken at the genetic, biochemical, or morphological level, among others. Optical spectral methods such as Raman spectroscopy aim at rapid and non-destructive tissue analysis, where each spectrum generated reflects the individual molecular composition of an examined spot within a (heterogenous) tissue sample. Using a combination of supervised and unsupervised machine learning methods as well as a solid database of Raman spectra of native glioblastoma samples, we succeed not only in distinguishing explicit tumor areas-vital tumor tissue and necrotic tumor tissue can correctly be predicted with an accuracy of 76%-but also in determining and classifying different spectral entities within the histomorphologically distinct class of vital tumor tissue. Measurements of non-pathological, autoptic brain tissue hereby serve as a healthy control since their respective spectroscopic properties form an individual and reproducible cluster within the spectral heterogeneity of a vital tumor sample. The demonstrated decipherment of a spectral glioblastoma heterogeneity will be valuable, especially in the field of spectroscopically guided surgery to delineate tumor margins and to assist resection control.</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>Computational Assessment of Spectral Heterogeneity within Fresh Glioblastoma Tissue Using Raman Spectroscopy and Machine Learning Algorithms.</pubmed_title><pmcid>PMC10935394</pmcid><funding_grant_id>FNR PEARL P16/BM/11192868</funding_grant_id><pubmed_authors>Kleine Borgmann FB</pubmed_authors><pubmed_authors>Arroteia IF</pubmed_authors><pubmed_authors>Klamminger GG</pubmed_authors><pubmed_authors>Slimani R</pubmed_authors><pubmed_authors>Husch A</pubmed_authors><pubmed_authors>Hertel F</pubmed_authors><pubmed_authors>Mombaerts L</pubmed_authors><pubmed_authors>Mirizzi G</pubmed_authors><pubmed_authors>Klein K</pubmed_authors><pubmed_authors>Jelke F</pubmed_authors><pubmed_authors>Frauenknecht KBM</pubmed_authors><pubmed_authors>Mittelbronn M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Computational Assessment of Spectral Heterogeneity within Fresh Glioblastoma Tissue Using Raman Spectroscopy and Machine Learning Algorithms.</name><description>Understanding and classifying inherent tumor heterogeneity is a multimodal approach, which can be undertaken at the genetic, biochemical, or morphological level, among others. Optical spectral methods such as Raman spectroscopy aim at rapid and non-destructive tissue analysis, where each spectrum generated reflects the individual molecular composition of an examined spot within a (heterogenous) tissue sample. Using a combination of supervised and unsupervised machine learning methods as well as a solid database of Raman spectra of native glioblastoma samples, we succeed not only in distinguishing explicit tumor areas-vital tumor tissue and necrotic tumor tissue can correctly be predicted with an accuracy of 76%-but also in determining and classifying different spectral entities within the histomorphologically distinct class of vital tumor tissue. Measurements of non-pathological, autoptic brain tissue hereby serve as a healthy control since their respective spectroscopic properties form an individual and reproducible cluster within the spectral heterogeneity of a vital tumor sample. The demonstrated decipherment of a spectral glioblastoma heterogeneity will be valuable, especially in the field of spectroscopically guided surgery to delineate tumor margins and to assist resection control.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-24T03:09:10.955Z</modification><creation>2026-06-24T03:06:19.491Z</creation></dates><accession>S-EPMC10935394</accession><cross_references><pubmed>38474491</pubmed><doi>10.3390/molecules29050979</doi></cross_references></HashMap>